tiprankstipranks
Rocket Pharma (RCKT)
NASDAQ:RCKT
US Market
RCKT
Rocket Pharmaceuticals
RESEARCH TOOLSreports
Want to see RCKT full AI Analyst Report?

Rocket Pharmaceuticals (RCKT) Income Statement

1,714 Followers

Rocket Pharmaceuticals Income Statement

Last quarter (Q4 2025), Rocket Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Rocket Pharmaceuticals's net income was $-42.54M. See Rocket Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -11.03M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 217.49M$ 273.20M$ 259.66M$ 224.34M$ 167.25M
Depreciation and Amortization
$ 11.03M$ 9.38M$ 7.10M$ 6.27M$ 5.37M
EBITDA
$ -210.21M$ -247.49M$ -236.62M$ -213.69M$ -157.81M
Operating Income
$ -228.52M$ -273.20M$ -259.66M$ -224.34M$ -167.25M
Other Income/Expenses
$ 5.39M$ 14.46M$ 14.06M$ 2.48M$ -1.82M
Pretax Income
$ -223.12M$ -258.75M$ -245.59M$ -221.86M$ -169.07M
Net Income
$ -223.12M$ -258.75M$ -245.59M$ -221.86M$ -169.07M
Per Share Metrics
Basic EPS
$ -2.01$ -2.73$ -2.92$ -3.26$ -2.68
Diluted EPS
$ -2.01$ -2.73$ -2.92$ -3.26$ -2.68
Weighted Average Shares Outstanding
 111.12M 94.81M 84.01M 68.15M 63.24M
Weighted Average Shares Outstanding (Diluted)
 111.12M 94.81M 84.01M 68.15M 63.24M
Currency in USD

Rocket Pharmaceuticals Earnings and Revenue History